About Kyverna Therapeutics
Kyverna Therapeutics is a private company based in Emeryville, California. It has reported $151,999,981 raised in one offering on Form D since November 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2021 | Nov 7, 2023 | $151,999,981fully sold | 24 | $6.3M | Equity, Shares issued in partial consideration the licenses and rights granted to the Company by the investor.Rule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kyverna Therapeutics's Form D filed Nov 7, 2023.
BK
Brian Kotzin
Director
IC
Ian Clark
Director
RJ
Ryan Jones
Chief Financial Officer
KW
Karen Walker
Executive officer
PM
Peter Maag
Executive officer and director
JC
James Chung
Executive officer
DS
Dan Spiegelman
Director
BS
Beth Spiegelman
Director
FC
Fred Cohen
Director
SL
Steve Liapis
Director
DB
Dominic Borie
Executive officer